Northwire Canada EditionFriday, October 16, 2026
Sign inSubscribe
Northwire
⌕
GOLD 4170.10 +1.5% SILVER 57.16 +2.3% COPPER 6.56 −1.5% OIL 97.97 +3.0% PALLADIUM 1136.00 +3.6% LUN 32.91 +0.6% DLP 0.290 −3.3% VCV 0.065 −13.3% GG 2.89 +1.4% NBLC 0.015 +0.0% SF 0.300 −4.8% ATY 0.215 +2.4% GHL 0.060 −7.7% STND 0.060 −7.7% B 0.550 −3.5% HBM 34.33 −0.5% NTR 98.77 −0.7% SGZ 0.035 +0.0% MKA 0.670 +0.0% LXM 0.175 −18.6% CLCH 1.08 −1.8% GOLD 4170.10 +1.5% SILVER 57.16 +2.3% COPPER 6.56 −1.5% OIL 97.97 +3.0% PALLADIUM 1136.00 +3.6% LUN 32.91 +0.6% DLP 0.290 −3.3% VCV 0.065 −13.3% GG 2.89 +1.4% NBLC 0.015 +0.0% SF 0.300 −4.8% ATY 0.215 +2.4% GHL 0.060 −7.7% STND 0.060 −7.7% B 0.550 −3.5% HBM 34.33 −0.5% NTR 98.77 −0.7% SGZ 0.035 +0.0% MKA 0.670 +0.0% LXM 0.175 −18.6% CLCH 1.08 −1.8%
Financings

Algernon increases placement, closes third tranche

By The Northwire Desk — AI Analysis Dec 23, 2025 · 19:00 AGN · 0.08 Algernon Health Inc
AGN · Price

Executive Summary

  • Algernon Health Inc. has closed the third tranche of its non-brokered private placement, increasing the total financing raised to $739,500.
  • The third tranche consisted of 5,035,714 units sold at $0.07 per unit, generating gross proceeds of $352,500.
  • Proceeds will be used to advance the company's Alzheimer's disease program, including opening its first U.S. clinic, covering general and administrative expenses, and working capital.

Key Details

  • Total Financing: The total gross proceeds from the private placement are now $739,500.
  • Third Tranche Details:
    • Gross Proceeds: $352,500
    • Units Sold: 5,035,714 units
    • Price Per Unit: $0.07
  • Previous Tranches:
    • First Tranche Closed: November 14, 2025
    • Second Tranche Closed: November 28, 2025
  • Total Units Issued: 10,564,286 units (cumulative across all three tranches).
  • Use of Proceeds: Advancing the Alzheimer's disease program, opening the first U.S. AD clinic, general and administrative expenses, and working capital.
  • Fees: No cash finders' fees were paid for the third tranche.
  • Restrictions: Securities are subject to a statutory hold period of four months plus one day from the date of issuance under Canadian securities legislation.

Notable Quotes

  • None provided in the text.
Read the original news release →

More from Algernon Health Inc

Mar 23, 2026 · 15:15

Algernon Health to open brain PET scanning clinic

Production / Operations Mar 23, 2026 · 07:00

Algernon to Open the First Brain Dedicated PET Scanning Clinic in the U.S. at the HCA Florida University Medical Office Building

Production / Operations Dec 31, 2025 · 16:01

Algernon Announces Additional Increase to Private Placement Financing to $858,000 and Final Closing of the Financing

Financings Dec 23, 2025 · 16:01

Algernon Announces Increase to Private Placement Financing to $750,000 and Close of Third Tranche

Financings Nov 28, 2025 · 20:25

Algernon Health closes second tranche of financing

Financings Nov 28, 2025 · 19:51

Algernon Closes Second Tranche of Private Placement Financing

Financings